ID: ALA3329553
Chembl Id: CHEMBL3329553
PubChem CID: 118712454
Max Phase: Preclinical
Molecular Formula: C15H14N6S2
Molecular Weight: 342.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(NC(=S)Nn2c(S)nnc2-c2ccncc2)cc1
Standard InChI: InChI=1S/C15H14N6S2/c1-10-2-4-12(5-3-10)17-14(22)20-21-13(18-19-15(21)23)11-6-8-16-9-7-11/h2-9H,1H3,(H,19,23)(H2,17,20,22)
Standard InChI Key: XCRLDAGSVZYKOC-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 342.45 | Molecular Weight (Monoisotopic): 342.0721 | AlogP: 2.88 | #Rotatable Bonds: 3 |
| Polar Surface Area: 67.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
| #RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 7.69 | CX Basic pKa: 3.58 | CX LogP: 2.53 | CX LogD: 2.36 |
| Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.50 | Np Likeness Score: -2.18 |
| 1. Kamel MM, Megally Abdo NY.. (2014) Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents., 86 [PMID:25147148] [10.1016/j.ejmech.2014.08.047] |
Source(1):
